Sienna Cancer Diagnostics /ics/ en Partnership to revolutionise cancer diagnostic /ics/news/list/2020/04/20/partnership-to-revolutionise-cancer-diagnostic The ³ÉÈË´óƬ has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licence agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells. April 20 2020 Rebecca Jane Farrell /ics/news/list/2020/04/20/partnership-to-revolutionise-cancer-diagnostic